Aquiline Capital Partners (Aquiline), a private investment firm with over $10bn in AUM, has made a majority investment in PharmaForce, a pharmacy solutions provider to hospitals and health clinics. Financial terms of the deal have not been disclosed.
The provider has delivered 340B administration software to over 280 clients since its inception in 2017 and recently launched a pharmacy benefits management offering.
In a press statement, PharmaForce said that, with Aquiline’s backing, it will “accelerate strategic M&A and continue to expand its product capabilities”.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Piper Sandler served as financial advisor to PharmaForce. Legal counsel was provided by Taft and Ropes & Gray to PharmaForce and Aquiline respectively.
Source: Private Equity Wire
Can’t stop reading? Read more
Carlyle plans structured financing to seed flagship Carlyle Partners IX fund
Carlyle plans structured financing to seed flagship Carlyle Partners IX fund Carlyle is exploring...
CVC secures €3.7bn financing for Global Sport Group backed by KKR and Pimco
CVC secures €3.7bn financing for Global Sport Group backed by KKR and Pimco CVC Capital Partners...
Bain Capital secures $12.5bn across Asia and Japan buyout funds
Bain Capital secures $12.5bn across Asia and Japan buyout funds Bain Capital has raised $12.5bn...